Change in serum hyaluronan: A simple index of short-term drug-induced changes in hepatic sinusoidal perfusion

Gastroenterology

Volumn 105, Issue 2, 1993, Pages 470-474

  Gibson, Peter R ^a   Fraser, J R E ^a   Colman, John C ^b   Jones, Penelope A ^b   Jennings, Garry ^b   Dudley, Francis J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; INDOCYANINE GREEN; KETANSERIN;

ALCOHOL LIVER DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; LIVER BLOOD FLOW; LIVER PERFUSION; LIVER SINUSOID; ORAL DRUG ADMINISTRATION; PORTAL HYPERTENSION; PRIORITY JOURNAL;

AGED; HEMODYNAMICS; HUMAN; HYALURONIC ACID; KETANSERIN; LIVER CIRCULATION; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0027194165     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(93)90721-N     Document Type: Article

References (26)

1. Propranolol-a medical treatment for portal hypertension?
2. Propranolol for prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis. A controlled study
3. Plasma clearance, tissue distribution, and metabolism of hyaluronan injected intravenously in the rabbit
4. Elimination of hyaluronic acid from the blood stream in the human
5. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver
6. Uptake of circulating hyaluronic acid by the rat liver
7. Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis
8. A pharmacokinetic model of intravenously administered hyaluronan in sheep
9. Hemodynamic and liver function predictors of serum hyaluronate in alcoholic liver disease
10. Increased serum levels of hyaluronate in liver disease
11. Serum hyaluronate in primary biliary cirrhosis—a biochemical marker of progressive liver damage
12. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease
13. Serum hyaluronate in liver diseases: study by enzymoimmunological assay
14. Dose-dependent effects of ketanserin on splanchnic and systemic haemodynamics in cirrhosis (abstr)
15. Quantitative analysis of hyaluronate in nanogram amounts
16. A convenient radiometric assay for hyaluronan
17. Can intrahepatic shunting be measured?
18. Scavenger functions of the liver endothelial cell
19. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients
20. Elevated levels of plasma hyaluronan in septicaemia
21. Circulating hyaluronate in rheumatoid arthritis The relationship to inflammatory activity and the effect of corticosteroid therapy
22. Elevated serum hyaluronate in scleroderma
23. Circulating hyaluronate in psoriasis
24. Hepatic endothelial cells. Targets in liver allograft rejection
25. Hyaluronic acid in the assessment of liver graft function